-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Cyclacel Pharmaceuticals, Inc. annual/quarterly Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2012 to Q1 2023.
- Cyclacel Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2023 was $6K, a 50% increase year-over-year.
- Cyclacel Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $6K, a 14.3% decline from 2022.
- Cyclacel Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $7K, a 74.1% decline from 2021.
- Cyclacel Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $27K, a 71.9% decline from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)